-
Founded in:
1999-09-09 -
Country:
China -
Address:
No. 43, Guoyang, Jingyang Industrial Zone, Fuqing City, Fuzhou City, Fujian Province -
Tax NO.:
913501817053865132 -
Registered Funds:
12.8 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Isatidis Radix |
|
0 | ||
| ISATIDIS FOLIUM |
|
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Yanhusuo |
|
0 | ||
| REHMANNIAE RADIX PRAEPARATA |
|
0 | ||
| Chrysophanic acid |
|
481-74-3 | 0 | |
| AURANTII FRUCTUS |
|
0 | ||
| Bupleurum |
|
0 | ||
| Linderae Radix |
|
0 | ||
| Aucklandiae Radix |
|
0 | ||
| PAEONIAE RADIX ALBA |
|
0 | ||
| CURCUMAE RADIX |
|
0 | ||
| CARTHAMI FLOS |
|
0 | ||
| Wulingzhi |
|
0 | ||
| Radix aconiti preparata |
|
0 | ||
| SAPOSHNIKOVIAE RADIX |
|
0 | ||
| POLLEN TYPHAE |
|
0 | ||
| MOUTAN CORTEX |
|
0 | ||
| To break off |
|
0 | ||
| NOTOGINSENG RADIX ET RHIZOMA |
|
0 | ||
| Angelicae Sinensis Radix |
|
0 | ||
| CYPERI RHIZOMA |
|
0 | ||
| Citri Reticulatae Pericarpium Viride |
|
0 | ||
| Zedoary turmeric |
|
0 | ||
| Rhizoma Sparganii Extract |
|
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Pantoprazole Sodium |
This product is a proton pump inhibitor for gastric parietal cells. It is relatively stable under neutral and weakly acidic conditions and rapidly activated under strongly acidic conditions. Its pH-dependent activation characteristics make it more selective for H and K-ATPase. This product can specifically inhibit the H and K-ATPase on the secretory microtubules and tubular vesicles in the cytoplasm of the parietal cell apical membrane, causing irreversible inhibition of the enzyme, thereby effectively inhibiting the secretion of gastric acid. Since H and K-ATPase are the last process of acid secretion in parietal cells, this product has a strong acid-suppressing ability. It can not only non-competitively inhibit gastric acid secretion caused by gastrin, histamine, and choline, but also inhibit some basal gastric acid secretion that is not affected by choline or H2 receptor blockers. When used with other drugs, this product has the advantage of small drug interactions. This product is metabolized through the I system of the cytochrome P450 enzyme system in hepatocytes, and can also be metabolized through the II system. When used with other drugs that are metabolized by the P450 enzyme system, the metabolic pathway of this product can be carried out through the II enzyme system, which makes it less likely to have competitive effects on the drug-metabolizing enzyme system and reduce the interaction between drugs in the body. It has no mutagenic, carcinogenic and teratogenic effects.
More
This product is a proton pump inhibitor for gastric parietal cells. It is relatively stable under neutral and weakly acidic conditions and rapidly activated under strongly acidic conditions. Its pH-dependent activation characteristics make it more selective for H and K-ATPase. This product can specifically inhibit the H and K-ATPase on the secretory microtubules and tubular vesicles in the cytoplasm of the parietal cell apical membrane, causing irreversible inhibition of the enzyme, thereby effectively inhibiting the secretion of gastric acid. Since H and K-ATPase are the last process of acid secretion in parietal cells, this product has a strong acid-suppressing ability. It can not only non-competitively inhibit gastric acid secretion caused by gastrin, histamine, and choline, but also inhibit some basal gastric acid secretion that is not affected by choline or H2 receptor blockers. When used with other drugs, this product has the advantage of small drug interactions. This product is metabolized through the I system of the cytochrome P450 enzyme system in hepatocytes, and can also be metabolized through the II system. When used with other drugs that are metabolized by the P450 enzyme system, the metabolic pathway of this product can be carried out through the II enzyme system, which makes it less likely to have competitive effects on the drug-metabolizing enzyme system and reduce the interaction between drugs in the body. It has no mutagenic, carcinogenic and teratogenic effects. |
138786-67-1 | 58 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Andrographis paniculata leaf powder |
Clears away heat, relieves inflammation, and detoxifies
More
Clears away heat, relieves inflammation, and detoxifies |
0 | ||
| Wild chrysanthemum (whole herb) |
Clears away heat, relieves inflammation, and detoxifies
More
Clears away heat, relieves inflammation, and detoxifies |
0 | ||
| Golden flower |
Clears away heat, relieves inflammation, and detoxifies
More
Clears away heat, relieves inflammation, and detoxifies |
0 | ||
| Blue Ginseng |
Clears away heat, relieves inflammation, and detoxifies
More
Clears away heat, relieves inflammation, and detoxifies |
0 | ||
| wild papaya |
Clears away heat, relieves inflammation, and detoxifies
More
Clears away heat, relieves inflammation, and detoxifies |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| lycii Fructus |
|
0 | ||
| Chrysanthemum |
|
0 | ||
| REHMANNIAE RADIX PRAEPARATA |
|
0 | ||
| Wine Cornus officinalis |
|
0 | ||
| MOUTAN CORTEX |
|
0 | ||
| Wild Yam P.E Diosgenine 7%-16% |
|
0 | ||
| Poria |
|
0 | ||
| ALISMATIS RHIZOMA |
|
0 | ||
| Sucrose |
|
57-50-1 | 72 | |
| Talc |
|
14807-96-6 | 26 |